ATI RN
ATI Pharmacology 2023 Questions
Extract:
Question 1 of 5
A nurse is preparing to administer cefazolin 1 g in 0.9% sodium chloride 100 ml- via intermittent IV bolus over 30 min. The drop factor of the manual IV tubing is I5 gtt/mL. The nurse should set the manual IV infusion to deliver how many gtt/min? (Round the answer to the nearest whole number. Use a leading zero if it applies. Do not use a trailing zero.)
Correct Answer: A
Rationale:
To calculate the IV infusion rate, first, convert the infusion time to minutes (30 min).
Then, calculate the total volume to be infused (100 mL). Next, determine the total number of drops needed (15 gtt/mL x 100 mL) = 1500 drops. Finally, divide the total drops by the infusion time in minutes (1500 drops / 30 min) = 50 gtt/min. This is why choice A (50) is correct.
Choices B, C, and D are incorrect as they do not match the calculated infusion rate.
Question 2 of 5
A nurse is preparing to transcribe a prescription for a client that reads 'ondansetron 8 mg by mouth every 12 hr PRN.' Which of the following parts of the prescription should the nurse clarify with the provider?
Correct Answer: D
Rationale: The correct answer is D: Reason. The nurse should clarify the reason for the prescription with the provider because it is important to understand the underlying condition or symptoms the medication is intended to treat. This information helps ensure the appropriateness of the prescription and aids in monitoring the client's response to the medication. Clarifying the dose (
A), route (
B), and frequency (
C) are essential but the reason (
D) behind the prescription is crucial for safe and effective medication administration.
Choices E, F, and G are not applicable in this scenario.
Question 3 of 5
A nurse is caring for a client who has a prescription for nifedipine. Which of the following findings should the nurse assess prior to administration of the medication?
Correct Answer: A
Rationale: The correct answer is A: Blood pressure. Nifedipine is a calcium channel blocker used to treat hypertension. Before administering, the nurse should assess the client's blood pressure as this medication can cause hypotension as a side effect. Monitoring blood pressure ensures safety and effectiveness of the medication. Assessing respiratory rate, temperature, and oxygen saturation are important but not specific to nifedipine administration. Blood pressure is the priority assessment in this case.
Question 4 of 5
A nurse is providing teaching to a client who has a new prescription for carbamazepine for the treatment of seizures. The nurse should instruct the client to monitor for which of the following adverse effects?
Correct Answer: A
Rationale: The correct answer is A: Blurred vision. Carbamazepine is known to cause ocular side effects, including blurred vision. The rationale is that carbamazuepine can lead to changes in the eye's ability to focus, causing blurred vision as a common adverse effect. This is important for the client to monitor because it can impact their daily activities and driving. The other choices, B: Insomnia, C: Metallic taste, and D: Tachypnea, are not typically associated with carbamazepine use. Insomnia is more commonly seen with stimulant medications, metallic taste is associated with certain antibiotics, and tachypnea is not a common side effect of carbamazepine.
Therefore, the correct answer is A because it directly relates to the medication's known adverse effects.
Question 5 of 5
A nurse is reviewing the laboratory data of a client who is receiving filgrastim. Which of the following laboratory values should the nurse monitor to evaluate the effectiveness of the treatment?
Correct Answer: D
Rationale: The correct answer is D: WBC count. Filgrastim is a medication that stimulates the production of white blood cells (WBCs). Monitoring the WBC count is essential to evaluate the effectiveness of the treatment as an increase in WBC count indicates that the medication is working to boost the immune system.
A: Potassium level is not directly related to filgrastim therapy.
B: BUN (blood urea nitrogen) is not typically affected by filgrastim.
C: INR (International Normalized Ratio) is a measure of blood clotting and is not relevant to monitoring filgrastim therapy.
Therefore, the correct choice is D as it directly reflects the intended therapeutic effect of filgrastim.